Crystalline and amorphous forms of efaproxiral sodium

Details for Australian Patent Application No. 2005234789 (hide)

Owner Allos Therapeutics, Inc.

Inventors Murray, Chris; Jonaitis, David T.; Parent, Stephan D.; Johnson, Douglas G.

Agent Davies Collison Cave

Pub. Number AU-A-2005234789

PCT Pub. Number WO2005/102308

Priority 60/564,721 22.04.04 US; 60/564,308 22.04.04 US

Filing date 22 April 2005

Wipo publication date 3 November 2005

International Classifications

A61K 31/245 (2006.01)

A61K 31/195 (2006.01)

A61K 31/325 (2006.01) - Carbamic acids

C07C 45/00 (2006.01) Preparation of compounds having CO groups bound only to carbon or hydrogen atoms

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/102308 Priority application(s): WO2005/102308

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005234793-Implantable prosthetic valve

2005234788-Coadministration of radiation, efaproxiral sodium, and supplemental oxygen for the treatment of cancer